Big Pharma Split Corp Class A Net Asset Quality Index
Big Pharma Split Corp Class A net asset quality index. Big Pharma Split Corp Class A (PRM) has a Net Asset Quality Index of 58.1% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CA$33.47 Million minus total liabilities of CA$14.04 Million yields net assets of CA$19.44 Million. A higher index indicates a stronger, lower-leverage balance sheet. See PRM book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Big Pharma Split Corp Class A (2017–2025)
Net asset quality index of Big Pharma Split Corp Class A from 2017 to 2025. This chart shows how Big Pharma Split Corp Class A's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the index stands at 58.1%, representing net assets of CA$19.44 Million against total assets of CA$33.47 Million CAD. Check PRM strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Big Pharma Split Corp Class A Net Asset Quality Index by Year (2017–2025)
Big Pharma Split Corp Class A net asset quality index by year from 2017 to 2025. The table below presents the year-by-year Net Asset Quality Index for Big Pharma Split Corp Class A from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PRM company net worth.
| Year | Quality Index | Net Assets (CAD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 57.4% | CA$18.27 Million | CA$31.84 Million | CA$13.57 Million | ▲ +5.4 pp |
| 2024 | 52.0% | CA$13.68 Million | CA$26.30 Million | CA$12.62 Million | ▼ -7.7 pp |
| 2023 | 59.7% | CA$15.85 Million | CA$26.53 Million | CA$10.68 Million | ▲ +9.3 pp |
| 2022 | 50.5% | CA$19.73 Million | CA$39.10 Million | CA$19.37 Million | ▼ -8.8 pp |
| 2021 | 59.2% | CA$22.40 Million | CA$37.81 Million | CA$15.41 Million | ▲ +1.8 pp |
| 2020 | 57.5% | CA$13.19 Million | CA$22.93 Million | CA$9.75 Million | ▼ -2.5 pp |
| 2019 | 60.0% | CA$16.31 Million | CA$27.18 Million | CA$10.87 Million | ▲ +4.0 pp |
| 2018 | 56.0% | CA$18.84 Million | CA$33.63 Million | CA$14.79 Million | ▼ -1.5 pp |
| 2017 | 57.5% | CA$18.68 Million | CA$32.49 Million | CA$13.81 Million | — |